QI
OXFD

QS Investors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

QS Investors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-59,014
Closed -$691K – 1283
2020
Q3 		$691K Hold
59,014
– – 0.01% 571
2020
Q2 		$768K Hold
59,014
– – 0.01% 807
2020
Q1 		$547K Buy
59,014
+3,714
+7% +$51.9K 0.01% 823
2019
Q4 		$943K Sell
55,300
-1,900
-3% -$30.8K 0.01% 793
2019
Q3 		$952K Hold
57,200
– – 0.01% 791
2019
Q2 		$788K Buy
57,200
+5,800
+11% +$88.7K 0.01% 867
2019
Q1 		$886K Buy
+51,400
New +$813K 0.01% 849

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QS Investors's OXFD Position: Q4 2020 in Review

QS Investors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 59,014 shares — an estimated $691K sold.

QS Investors first reported a position in OXFD in Q1 2019 and held it in 7 quarters. The position peaked at $952K in Q3 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

  • QS Investors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 59,014 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $691K.
  • QS Investors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and held it in 7 quarters.
  • QS Investors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $952K in Q3 2019.
  • 60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.